High Fusion Inc.

Recent News

  • High Fusion Inc. Announces Replacement of Director

    Toronto, Ontario--(Newsfile Corp. - January 31, 2023) - High Fusion Inc. (CSE: FUZN) ("High Fusion" or the "Company") announces the replacement of one of its directors.Effective immediately, Aaron Johnson has resigned his position as director of the Company. The board position will be replaced by Mr. Ross Mitgang. Ross currently serves as controller of Plaza Capital, a boutique merchant banking and advisory firm and is a director on several public and private companies."We would like to thank Aaron...

    2023-01-31 4:45 PM EST
  • High Fusion Inc. Announces Change to Board of Directors and Compensation to Management and Directors

    Toronto, Ontario--(Newsfile Corp. - January 20, 2023) - High Fusion Inc. (CSE: FUZN) ("High Fusion" or the "Company") announces the replacement of one of its directors and grant of compensation to management and directors.Effective immediately, Lincoln Fish has resigned his position as director and executive of the Company. The board position will be replaced by Austin Birch who will be included in the proposed slate of directors at the upcoming meeting of the shareholders to be announced shortly. ...

    2023-01-20 4:45 PM EST
  • High Fusion Inc. Announces Closing of Investments

    Toronto, Ontario--(Newsfile Corp. - December 28, 2022) - High Fusion Inc. (CSE: FUZN) ("High Fusion" or the "Company") is pleased to announce that it has successfully completed two investments in the aggregate amount of approximately US$250,000.The first investment of US$100,000 ($135,000) represents a purchase of 1,350,000 multiple voting shares of the Company at a price of $.10 per share based on the price of the listed subordinate voting shares as determined by policies of the Canadian Securities Exchange. The...

    2022-12-28 12:57 PM EST
  • High Fusion Announces Application for Management Cease Trade Order Is Denied

    Toronto, Ontario--(Newsfile Corp. - November 17, 2022) - High Fusion Inc. (CSE: FUZN) (OTC Pink: SPLIF) ("High Fusion" or the "Company") announces that its request for a Management Cease Trade Order ("MCTO") was denied on November 16, 2022, by the Ontario Securities Commission ("OSC").Pursuant to National Policy 12-203 - Management Cease Trade Orders ("NP 12-203"), the Company notified OSC on November 15, 2022, that it anticipated a delay in filing its financial statements for the year-ended July 31, 2022, and...

    2022-11-17 9:50 AM EST
  • High Fusion Announces Application for Management Cease Trade Order

    Toronto, Ontario--(Newsfile Corp. - November 15, 2022) - High Fusion Inc. (CSE: FUZN) (OTC Pink: SPLIF) ("High Fusion" or the "Company") announces today that it has made an application to the Ontario Securities Commission to approve a temporary management cease trade order ("MCTO") under National Policy 12-203 – Management Cease Trade Orders ("NP 12-203"), which, if granted, will prohibit trading in securities of the Company by its Chief Executive Officer and Chief Financial Officer so long as the 2022 Filings (as defined...

    2022-11-15 2:13 PM EST
  • High Fusion and Its Psychedelics Subsidiary Neural Therapeutics Enter into Arrangement Agreement

    Toronto, Ontario--(Newsfile Corp. - November 4, 2022) - High Fusion Inc. (CSE: FUZN) ("High Fusion" or the "Company") is pleased to announce that it has entered into a definitive arrangement agreement (the "Agreement") with Neural Therapeutics Inc. ("Neural") with respect to the distribution of a approximately one quarter of High Fusion's shareholdings in Neural to High Fusion shareholders ("Transaction").High Fusion CEO John Durfy commented, "This strategic spin-out of our holdings in Neural, featuring its own leadership team, is designed to...

    2022-11-04 8:00 AM EDT
  • High Fusion's Psychedelics Subsidiary Neural Therapeutics Announces Significant Business and Corporate Milestones

    Toronto, Ontario--(Newsfile Corp. - September 12, 2022) - High Fusion Inc. (CSE: FUZN) ("High Fusion" or the "Company") is pleased to announce a corporate strategy update of its partially-owned subsidiary, Neural Therapeutics Inc. ("Neural").Intellectual Property AchievementsIn partnership and collaboration with its extraction partners based in Nevada, Neural has developed a new and novel extraction methodology for full spectrum Mescaline and Mescaline isolate from the San Pedro plant. Neural has submitted a provisional patent application on August 26, 2022 to...

    2022-09-12 9:04 AM EDT
  • High Fusion Inc. Announces Amendment to Debentures

    Toronto, Ontario--(Newsfile Corp. - August 3, 2022) - High Fusion Inc. (CSE: FUZN) ("High Fusion" or the "Company") is pleased to announce an extension of the term of the August 2018 senior secured debentures ("Debentures") from August 3, 2022 to February 3, 2023.With the extension of the maturity date of the Debentures, the interest on the debentures to maturity will increase to 24% per annum. One half of the interest on the Debentures shall be added to the principal amount...

    2022-08-03 9:22 AM EDT